Abbott Laboratories (ABT) Stock Price, Quote & News

Company Profile

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement th...

Industry: Medical Devices

Sector: Healthcare

Phone: 224 667 6100

Website: www.abbott.com

Address:

100 Abbott Park Road, Abbott Park, North Chicago, United States

swingingtech Jun. 21 at 12:13 AM

$META $PLTR $ABT $SD https://wallstreetwaves.com/key-insights-from-research-reports-on-meta-platforms-palantir-and-abbott/

0 · Reply

Candcout Jun. 20 at 5:57 PM

$ABT

0 · Reply

IN0V8 Jun. 20 at 2:52 PM

$ABT Jefferies raises target price to $143 from $137

0 · Reply

Rage_Against_The_Machine Jun. 19 at 7:59 PM

Strategic move for $ABT: Partnering with Abu Dhabi's health authority to localize pharma manufacturing and boost digital health solutions. This aligns with emerging market expansion goals while addressing supply chain risks. High-impact play for long-term positioning in MENA healthcare leadership. https://www.prnewswire.com/news-releases/the-department-of-health--abu-dhabi-and-abbot-unite-to-manufacture-pharmaceuticals-locally-in-abu-dhabi-302486604.html

0 · Reply

Rage_Against_The_Machine Jun. 19 at 3:21 PM

Kalorama's latest IVD report highlights $ABT as a key innovator in infectious disease testing. With POC solutions and molecular platforms driving growth, Abbott's R&D investments (up 4.5% YoY) position them well in this $XXB market. Today's update reinforces their defensive moat in diagnostics. https://www.prnewswire.com/news-releases/infectious-disease-testing-market-remains-dynamic-amid-post-pandemic-shifts-and-new-innovations-302485467.html

0 · Reply

Angiesix Jun. 17 at 8:44 PM

$KNW Stock should be priced about $13-14 with their BTC value on the balance sheet included. Now let BTC drop 50% this year/next in order to go bullish in 2027 or so, the stock should be trading at $7 the least. Without a product. When they release their product, this is a first to market product, billion dollar market to capture. $DXCM $ABT doesn't like competition and funds already showed what's going on ($DXCM 📉)

2 · Reply

IN0V8 Jun. 16 at 8:15 PM

$ABT Leerink Partners initiates coverage with market perform rating Leerink Partners initiates coverage with target price $143

0 · Reply

zoey1970 Jun. 13 at 3:21 PM

$MDT How Next-Gen Implants Are Making Seizure Prevention Smarter and Safer Than Ever An implantable chip could soon spot early epilepsy signals and intervene, significantly enhancing patients’ quality of life. At the heart of this innovation are Spiking Neural Networks (SNNs), a form of artificial intelligence that mimics the brain’s efficiency. These neuromorphic implantables, built on SNNs, mark notable progress toward energy-efficient AI, contrasting with traditional Artificial Neural Networks (ANNs) that operate nonstop like constant light sources. SNNs, in contrast, utilize event-triggered “spikes” (brief electrical pulses), activating only as needed and thereby slashing energy use—a vital advantage for medical tools. Read more here if interested...https://neuromorphiccore.ai/how-next-gen-implants-are-making-seizure-prevention-smarter-and-safer-than-ever/ $BSX $ABT $NPCE $LIVN

0 · Reply

suntanner20 Jun. 13 at 1:17 PM

$MLSS Table Is Set: Everyone needs to eat. In fact, everyone loves to eat a great big home cooked meal, but not everyone loves to do what it takes to deliver that arduous task. That brings us to what potentially could be one of the most savoring investments in the micro cap space that just might be all set up for making that brokerage account adequately full when it’s all said and done. The investment is Milestone Scientific (MLSS .90) a medical device company that specializes in a device that delivers a one of a kind, AI pressurized syringe for the epidural market today, but the platform could bolster many new applications in the not too distant future. The reality is the company has done a lot of the heavy lifting to get themselves to invite as many new shareholders to the table that we believe is set to eat. Shanth Thiyagalingam Brought into MLSS 3 weeks ago COULD be the Chef needed to find all the ingredients $NVRO $ABT

0 · Reply

StocktwitsNews Jun. 10 at 4:07 PM

Tandem Diabetes Inks Deal With Abbott For New Diabetes Solutions: Retail Sentiment Stays Subdued $TNDM $ABT $IJR https://stocktwits.com/news/equity/markets/tandem-diabetes-inks-deal-with-abbott-for-new-diabetes-solutions/chl7YcyRbzF

1 · Reply

New Research on Abbott's Healthy Food Rx Program Shows 'Food is Medicine' Approach Helps People Living With Diabetes Eat Better and Feel Healthier

Jun 13, 2025, 11:34 AM EDT - 7 days ago

Abbott Declares 406th Consecutive Quarterly Dividend

Jun 10, 2025, 9:00 AM EDT - 11 days ago

The Highest-Quality Dividend Contenders By Quality Scores

AAPL ACN AMP AON CASS CMCSA COST

Jun 6, 2025, 4:08 PM EDT - 14 days ago

Healthcare companies are hiring. Is it time to look for growth stocks in this beaten-down sector?

ABBV JNJ LLY UNH XLV

May 27, 2025, 10:15 PM EDT - 24 days ago

Best Dividend Aristocrats For June 2025

ABBV ADM ADP AFL ALB AMCR AOS

May 27, 2025, 9:00 AM EDT - 25 days ago

Abbott Receives FDA Approval for Tendyne™, First-of-Its-Kind Device to Replace the Mitral Valve Without Open-Heart Surgery

May 27, 2025, 5:09 AM EDT - 25 days ago

Abbott Laboratories: Why Wall Street's Skepticism Misses The Real Story

May 15, 2025, 10:12 AM EDT - 5 weeks ago

Abbott India's quarterly profit climbs 28% on strong demand

May 15, 2025, 9:05 AM EDT - 5 weeks ago

Abbott's Libre® Technology is First Continuous Glucose Monitor Associated with Reduced Hospitalizations for Heart Complications in People with Diabetes

May 5, 2025, 3:10 PM EDT - 6 weeks ago

Abbott Labs CEO on federal health care spending, investing in healthy people and weight loss drugs

May 2, 2025, 5:59 PM EDT - 7 weeks ago

US judge allows testimony that Abbott and Mead Johnson preterm baby formula caused deadly disease

May 1, 2025, 9:00 AM EDT - 7 weeks ago

MotoAmerica Becomes First Sports Organization to Use Abbott's Rapid Blood Test for Concussion Evaluation On-site at Races

Apr 30, 2025, 4:12 PM EDT - 7 weeks ago

Healthy Returns: Here are the drugmakers with new U.S. investments as Trump's pharma tariffs loom

ABBV DXCM GSK JNJ LLY MRK NVS

Apr 29, 2025, 8:07 PM EDT - 7 weeks ago

Best Dividend Aristocrats For May 2025

ABBV ADM ADP AFL ALB AMCR AOS

Apr 29, 2025, 9:05 AM EDT - 7 weeks ago

Abbott Integrates Libre's Data with Epic's Electronic Health Record System, Providing Healthcare Professionals Seamless Glucose Monitoring Information

Apr 27, 2025, 2:15 PM EDT - 7 weeks ago

Abbott Highlights New AVEIR™ Data, Initiates Trial for the Company's Conduction System Pacing Technology

Apr 26, 2025, 7:15 PM EDT - 7 weeks ago

New Clinical Study Data Showcase Long-Term, Sustained Benefits of Abbott's Volt™ PFA System for Patients with AFib

Apr 23, 2025, 9:58 AM EDT - 2 months ago

2025 Dividend Kings: Weathering Tariff Volatility Better Than The Market

ABM ADM AWR BDX BKH CWT ED

Apr 19, 2025, 9:54 AM EDT - 2 months ago

Abbott Labs' Rally Is Well Deserved - Fade The Rally For Now

Apr 17, 2025, 11:11 AM EDT - 2 months ago

These Analysts Boost Their Forecasts On Abbott Laboratories After Better-Than-Expected Earnings

Apr 16, 2025, 3:57 PM EDT - 2 months ago

Abbott Q1: Flexible Supply Chain And Strong Growth In Medical Devices

Apr 16, 2025, 11:24 AM EDT - 2 months ago

Abbott Laboratories (ABT) Q1 2025 Earnings Call Transcript

Apr 16, 2025, 10:06 AM EDT - 2 months ago

Nasdaq Down Over 2%; Abbott Laboratories Posts Upbeat Earnings

Apr 16, 2025, 10:01 AM EDT - 2 months ago

Abbott Labs sees demand for diabetes products jump, and the stock surges

Apr 16, 2025, 8:23 AM EDT - 2 months ago

Abbott Labs Profit Jumps on Gains in Nutrition, Medical Devices

Apr 16, 2025, 8:14 AM EDT - 2 months ago

Abbott Laboratories Stock Slips as First-Quarter Sales Miss Expectations

Apr 16, 2025, 7:33 AM EDT - 2 months ago

Abbott beats quarterly profit estimate on strong medical device demand

Apr 16, 2025, 7:30 AM EDT - 2 months ago

Abbott Reports First-Quarter 2025 Results and Reaffirms Full-Year Guidance

Apr 15, 2025, 8:35 AM EDT - 2 months ago

How To Earn $500 A Month From Abbott Laboratories Stock Ahead Of Q1 Earnings

Mar 31, 2025, 4:07 PM EDT - 2 months ago

Best Dividend Aristocrats For April 2025

ABBV ADM BDX BEN BRO CAH CL

Mar 31, 2025, 9:00 AM EDT - 2 months ago

New Late-Breaking Data Reinforce Benefits of Abbott's TriClip™ for People With Leaky Tricuspid Heart Valve

Mar 27, 2025, 9:00 AM EDT - 3 months ago

Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms

Mar 26, 2025, 9:00 AM EDT - 3 months ago

Abbott Hosts Conference Call for First-Quarter Earnings

Mar 24, 2025, 9:00 AM EDT - 3 months ago

Abbott Initiates New Intravascular Lithotripsy Clinical Trial to Improve Outcomes in Patients with Coronary Artery Disease

Mar 21, 2025, 12:59 PM EDT - 3 months ago

2025 Dividend Kings: Strong Run Continues

ABBV ABM ADM AWR BDX BKH CWT

Mar 17, 2025, 7:49 AM EDT - 3 months ago

Abbott Stock Could Be On The Verge Of A Breakout - Here's What Smart Money Sees

Mar 7, 2025, 5:28 AM EST - 3 months ago

Strong Earnings Lift Abbott Laboratories Shares

Mar 5, 2025, 9:00 AM EST - 3 months ago

The Dividend Aristocrats Ranked By Quality Scores: March 2025

ABBV ADM ADP AFL ALB AMCR AOS

Mar 4, 2025, 11:38 AM EST - 3 months ago

Cagent Vascular Appoints Paul Wilson as Chief Commercial Officer to Drive Growth and Market Expansion

TFX

Mar 4, 2025, 8:00 AM EST - 3 months ago

Cadrenal Therapeutics Announces Collaboration Agreement with Abbott in Support of Pivotal Study of Tecarfarin in Patients with HeartMate 3™ LVAD

CVKD

Feb 27, 2025, 3:59 PM EST - 4 months ago

My Best Dividend Aristocrats For March 2025

ADM AFL ALB BDX BEN CHD CHRW

Feb 21, 2025, 10:48 AM EST - 4 months ago

Abbott Declares 405th Consecutive Quarterly Dividend

Feb 5, 2025, 11:03 PM EST - 4 months ago

Here are the best performing dividend aristocrats stocks in 2025

APD DOV IBM MDT

Feb 4, 2025, 11:27 AM EST - 4 months ago

Abbott's 'Above the Bias' Film Reveals Misconceptions Can Impact Diabetes Care

Jan 29, 2025, 3:11 AM EST - 5 months ago

My Best Dividend Aristocrats For February 2025

ADM ALB BEN CHRW ECL HRL MKC

Jan 27, 2025, 6:00 AM EST - 5 months ago

Is There More Upside For ABT Stock After A 10% Jump In A Week?

Jan 26, 2025, 3:27 PM EST - 5 months ago

Abbott Laboratories: Strong Q4 Results And Bullish Outlook

Jan 24, 2025, 3:14 AM EST - 5 months ago

What Can The Dividend Kings Deliver In 2025?

ABBV ABM ADM ADP AWR BDX BKH

Jan 23, 2025, 3:01 PM EST - 5 months ago

Why Is Abbott Stock Trading Higher On Thursday?

Jan 23, 2025, 12:48 PM EST - 5 months ago

Two Contrarian Dividends With Triple-Digit Potential For Trump 2.0

ADI

swingingtech Jun. 21 at 12:13 AM

$META $PLTR $ABT $SD https://wallstreetwaves.com/key-insights-from-research-reports-on-meta-platforms-palantir-and-abbott/

0 · Reply

Candcout Jun. 20 at 5:57 PM

$ABT

0 · Reply

IN0V8 Jun. 20 at 2:52 PM

$ABT Jefferies raises target price to $143 from $137

0 · Reply

Rage_Against_The_Machine Jun. 19 at 7:59 PM

0 · Reply

Rage_Against_The_Machine Jun. 19 at 3:21 PM

0 · Reply

Angiesix Jun. 17 at 8:44 PM

2 · Reply

IN0V8 Jun. 16 at 8:15 PM

$ABT Leerink Partners initiates coverage with market perform rating Leerink Partners initiates coverage with target price $143

0 · Reply

zoey1970 Jun. 13 at 3:21 PM

0 · Reply

suntanner20 Jun. 13 at 1:17 PM

0 · Reply

StocktwitsNews Jun. 10 at 4:07 PM

1 · Reply

Baxy007 Jun. 10 at 2:38 AM

$KNW Ok just need to talk about this for a bit. Give the newbies (last week's new followers) a little history lesson on why the OG longs were in this ticker. Don't get me wrong, Greg Kidd and his 1000 bitcoin injection, and his Vast Bank, USBC stablecoin with possible insurance is amazing. But let's rewind a bit. There's been no posts and DD in the past few days about Know Labs and their Non-Invasive Blood Glucose Monitoring sensor. Know Labs has over 300 patents issued or pending, with PCT'S filed, hundreds of trade secrets and is the leading IP holder in the "WORLD" in non invasive glucose monitoring. Their sensor can detect glucose, alcohol and many other analytes non-invasivley, no finger pricks to check blood glucose levels, no waste, a fraction of the cost to operate vs its competition like $DXCM Dexcom, $ABT Abbott Labs and $MDT Medtronics. Cont. Below

0 · Reply

swingingtech Jun. 9 at 2:06 PM

$EBAY $AGI $LYV $ABT https://wallstreetwaves.com/weekly-stock-grader-review-recent-changes-in-top-blue-chip-stock-ratings/

0 · Reply

aby1 Jun. 7 at 2:59 AM

$ABT I took a position today. Let's go.

1 · Reply

scottybebs Jun. 6 at 5:12 PM

$ABT why falling

0 · Reply

DavyDaveCharts Jun. 4 at 7:59 PM

$ABT and they absolutely did.

0 · Reply

hassanali1 Jun. 4 at 6:08 PM

$SENS On the positive side, the executives and the share holders of $ABT already made 5 percent on their investments, hopefully their decision will be fruitful for Humanity and share holders of both companies.

2 · Reply

aaxaa Jun. 3 at 6:26 PM

It's $ABT that time

0 · Reply

hassanali1 Jun. 3 at 3:07 AM

$SENS This is going to be like $ASXC, $ABT will buy this for 31 Cents. Share holders will be screwed again, proof me wrong I will be happy.

2 · Reply

WanaBBillionaire Jun. 2 at 4:04 PM

$ABT check out insider buying in WGS. It’s on the move today. Guggenheim Initiates GeneDx Holdings at Buy With $88 Price Target

0 · Reply

suntanner20 Jun. 2 at 12:37 PM

$MLSS this is going to be a serious little company if they put the pieces together. $ABT executive on board who's next?

0 · Reply

RunnerSignals May. 30 at 4:53 PM

$ABT Confident in $ABT long-term. CGM growth + strong diagnostics demand outweigh short-term FX pressure. Solid “buy the dip” candidate if market overreacts stocksrunner.com/symbol/ABT

0 · Reply

ZacksResearch May. 30 at 2:36 PM

$ABT sees a 21.6% jump in CGM sales and growing global diagnostics demand, while FX and macro pressure temper its outlook. Read more: https://www.zacks.com/stock/news/2479589/abbott-benefits-from-libre-biosimilars-amid-fx-cost-headwinds?cid=sm-stocktwits-2-2479589-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2479589_TEASER

0 · Reply

Market Cap	230.37B
Revenue (ttm)	41.95B
Net Income (ttm)	13.40B
EPS (ttm)	N/A
PE Ratio	27.67
Forward PE	25.68
Profit Margin	31.95%
Debt to Equity Ratio	0.27

Volume	11,338,100
Avg Vol	6,576,644
Day's Range	N/A - N/A
Shares Out	1.74B
Stochastic %K	35%
Beta	0.73
Analysts	Strong Sell
Price Target	$143.39